GO
Loading...

Endo Health Solutions Inc

  • NEW YORK, April 1- Energy stocks have further to fall before they look attractive, according to a fund manager who has made his name investing in out of favor companies. Daniel Kozlowski, portfolio manager of the $4.6 billion Janus Contrarian fund, is not adding oil-related stocks to his portfolio despite the price of crude dropping about 50 percent since last...

  • March 30- BioDelivery Sciences International Inc said its pain drug failed to meet the main goal of a late-stage study, sending the drugmaker's shares down nearly 30 percent. Janney Montgomery Scott LLC's Chiara Russo said the fall in share price was overdone as the company is developing another promising pain drug. Biodelivery, which is developing an opioid...

  • BUZZ-SALIX PHARMACEUTICALS PLC: VALEANT RAISES OFFER; ENDO. **Salix's shares up nearly 2 pct at $172.70, after Valeant Pharma raises bid and Endo International Plc pulls its offer. **Canada's Valeant raises its all-cash offer for Salix to $173 per share from $158, topping Endo's cash-and-stock offer of $172.56 as of Friday's close.

  • *Empire State manufacturing data misses estimates. March 16- U.S. stocks opened higher Monday and the benchmark S&P 500 rebounded after three weeks of losses as the euro strengthened against the dollar, easing some concerns over the impact of a robust greenback on corporate earnings. A recovery in the euro was reassuring investors, said Nick Colas, chief market...

  • US STOCKS-Wall St futures rise as euro recovers Monday, 16 Mar 2015 | 9:02 AM ET

    *Empire State manufacturing data miss estimates. March 16- U.S. stock index futures were up on Monday, putting the benchmark S&P 500 on track for a rebound after three weeks of losses, as currency markets helped reassure U.S. investors concerned about how a strong dollar would hurt earnings. A recovery in the euro was reassuring investors as a rapidly rising U.S....

  • BUZZ-SALIX PHARMACEUTICALS PLC: VALEANT RAISES ALL-CASH OFFER@** American drugmaker's shares up 2 pct at $173. **Canadian drugmaker Valeant Pharmaceuticals International Inc raised its offer to buy Salix to $173 from $158 in cash. **Sources told Reuters on Friday Valeant was working with its top shareholders on plans to raise its offer for Salix, sending Dublin-...

  • March 12- Endo International Plc's $11 billion offer this week for Salix Pharmaceuticals Ltd, an effort to trump an agreed $10 billion bid from Valeant Pharmaceutical Inc, illustrates CEO Rajiv De Silva's plan to be seen as not just a protege of Valeant chief Mike Pearson, but as a challenger. If successful, buying Raleigh, North Carolina- based Salix would combine...

  • The number of men being prescribed testosterone jumped more than 75 percent, to 2.3 million, between 2009 and 2013. About 70 percent of these patients were between the ages of 40 and 64, the FDA said. AbbVie Inc's AndroGel, one of the most widely-used products, raked in sales of $934 million in 2014. Other products include Endo International Plc's Testim and Eli...

  • *Markit manufacturing hits 4- month high. NEW YORK, March 2- U.S. stocks advanced on Monday, with the Nasdaq nudging above the 5,000 mark for the first time in 15 years, as a round of mixed data pointed to a slowly accelerating economy. Fundamentals are good enough at technology companies, the biggest group on Nasdaq, that the index should be able to stay above 5000, said...

  • *Markit manufacturing hits 4- month high, ISM hits 13- month low. NEW YORK, March 2- U.S. stocks advanced on Monday to push the Nasdaq above the 5,000 mark for the first time in fifteen years, as a round of mixed data pointed to a slowly accelerating economy. "Five thousand on the Nasdaq, it's been a long time coming," said Peter Kenny, chief market strategist at Clearpool...

  • *Manufacturing data expected from Markit, ISM. *HP to buy Aruba Networks. At 9:45 a.m., data will be released on the manufacturing sector by financial data firm Markit, following shortly afterwards by the Institute for Supply Management's reading on the manufacturing sector at 10:00 a.m..

  • *Manufacturing data expected from Markit, ISM. *HP to buy Aruba Networks. At 9:45 a.m., data will be released on the manufacturing sector by financial data firm Markit, following shortly afterwards by the Institute for Supply Management's reading on the manufacturing sector at 10:00 a.m..

  • *Manufacturing data expected from Markit, ISM. *Investors will also eye data on the manufacturing sector, with financial data firm Markit final Manufacturing Purchasing Managers Index expected at 9:45 a.m.. The Institute for Supply Management's reading on the manufacturing sector is scheduled for release at 10:00 a.m..

  • NEW YORK, Feb 20- Valeant Pharmaceuticals International Inc is close to a deal to acquire bowel drug maker Salix Pharmaceuticals Ltd for around $160 per share, according to a person directly familiar with the matter. A deal of that size would be the largest ever for Valeant, which lost a takeover contest for Allergan Inc last year. The usually acquisitive Valeant...

  • Jan 26- The U.S. Food and Drug Administration said it approved Teva Pharmaceutical Industries Ltd's generic version of AstraZeneca Plc's blockbuster heartburn drug Nexium, the agency's first such approval for the drug. Nexium raked in about $1.9 billion in global sales in the first half of 2014, according to AstraZeneca's latest earnings statement.

  • Nov 20- A U.S. court has denied a request by Indian drugmaker Ranbaxy Laboratories Ltd to stop competitors from launching copies of AstraZeneca Plc's heartburn pill Nexium and Roche's antiviral, a court filing showed. Ranbaxy had filed a lawsuit against the U.S. Food and Drug Administration last week for revoking tentative approvals it gave the company to make...

  • Nov 20- A U.S. court has denied a request by Indian drugmaker Ranbaxy Laboratories Ltd to stop competitors from launching copies of AstraZeneca Plc's heartburn pill Nexium and Roche's antiviral Valcyte, a court filing showed. Ranbaxy had sought the restraining order against Dr Reddy's Laboratories and U.S. firm Endo International Plc in a lawsuit it filed...

  • Nov 5- Endo International Plc raised its 2014 forecast for the third time and reported a better-than-expected quarterly profit, its recent acquisitions helping boost generic drug sales in the United States by nearly 74 percent. The Dublin- based maker of drugs and medical devices, which last month clinched a deal to buy Auxilium Pharmaceuticals Inc, raised its...

  • Nov 5- Endo International Plc, which is acquiring Auxilium Pharmaceuticals Inc, reported a better-than-expected quarterly profit due to a nearly 74 percent jump in sales of its generic drugs in the United States. The Dublin- based company's adjusted net income rose to $182.3 million in the quarter ended Sept. 30, from $160.7 million a year earlier.

  • Nov 3- Boston Scientific Corp on Monday was set to face its first federal trials in two courts over claims from women who say they were injured by the company's transvaginal mesh devices. Boston Scientific has been hit with more than 23,000 suits in U.S. state and federal courts over the devices in the six years since concerns were first publicly raised over the...